XML 85 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of allocated stock-based compensation

Stock-based compensation expense consisted of the following (in thousands):

Year Ended December 31, 

2020

    

2019

    

2018

Equity awards

$

10,551

$

8,105

$

7,388

Liability awards

 

1,521

 

2,336

 

1,096

Total stock-based compensation expense

$

12,072

$

10,441

$

8,484

Summary of stock option activity

Weighted

Weighted

Aggregate

Stock

Average

Average

Intrinsic

Options

Exercise Price

Remaining Life

Value

    

(in thousands)

    

per Share

    

    (in years)

    

(in thousands)

Options outstanding and exercisable, December 31, 2019

 

154

$

19.40

Canceled

 

(90)

 

15.32

Options outstanding and exercisable, December 31, 2020

 

64

25.18

0.2

$

Share-Based Compensation Measurement Inputs [Table Text Block]

Year Ended December 31, 

2020

2019

2018

Remaining performance period as of grant date (in years)

    

2.9

    

2.9

    

2.8

    

Risk-free interest rate used

 

1.4

%  

2.6

%  

2.4

%  

Grant-date fair value

$

11.33

$

12.91

$

13.46

Schedule of restricted stock, restricted stock unit, performance unit, cash settled restricted stock unit and cash settled performance unit activity

Weighted

Average

Grant Date

Fair Value

    

Shares

    

Per Share

Non-vested awards, December 31, 2019

 

2,022

$

10.25

Granted (1)

 

1,467

 

9.37

Vested (2)

 

(933)

 

10.39

Canceled

 

(110)

 

9.78

Non-vested awards, December 31, 2020 (3)

 

2,446

 

9.69

(1)The weighted average grant date fair value of shares granted during the years ended December 31, 2020, 2019 and 2018 was $9.37, $10.01 and $9.66, respectively.
(2)The total fair value of all awards vested during the years ended December 31, 2020, 2019 and 2018 was $7.1 million, $9.0 million and $8.2 million, respectively.
(3)Non-vested awards as of December 31, 2020 were comprised of 454,000 cash-settled restricted stock units and cash-settled performance units and 1,992,000 restricted stock, stock-settled restricted stock units and stock-settled performance-based restricted stock units.